128 related articles for article (PubMed ID: 17693084)
21. The two faces of cervical adenocarcinoma in situ.
Smedts F; Ramaekers FC; Hopman AH
Int J Gynecol Pathol; 2010 Jul; 29(4):378-85. PubMed ID: 20567153
[TBL] [Abstract][Full Text] [Related]
22. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
Portari EA; Russomano FB; de Camargo MJ; Machado Gayer CR; da Rocha Guillobel HC; Santos-Rebouças CB; Brito Macedo JM
Int J Gynecol Pathol; 2013 Sep; 32(5):501-8. PubMed ID: 23896712
[TBL] [Abstract][Full Text] [Related]
24. Robust expression of EZH2 in endocervical neoplastic lesions.
Makk E; Bálint L; Cifra J; Tornóczky T; Oszter A; Tóth A; Kálmán E; Kovács K
Virchows Arch; 2019 Jul; 475(1):95-104. PubMed ID: 30903272
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
26. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
27. [Cervical glandular intraepithelial neoplasia: a clinicopathologic and immunohistochemical analysis of 80 cases].
Luo R; Chen XD; Zhu LY
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):32-6. PubMed ID: 23611270
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
29. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.
Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K
Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
[TBL] [Abstract][Full Text] [Related]
31. Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.
He Y; Li L; Jiang W; Wang DQ; Xu L; Huang Q; Zhang Y; Yang KX
Pathol Res Pract; 2011 May; 207(5):295-9. PubMed ID: 21497449
[TBL] [Abstract][Full Text] [Related]
32. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
33. Cytologic findings in stratified mucin-producing intraepithelial lesion of the cervix: A report of 34 cases.
Backhouse A; Stewart CJ; Koay MH; Hunter A; Tran H; Farrell L; Ruba S
Diagn Cytopathol; 2016 Jan; 44(1):20-5. PubMed ID: 26493276
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions.
McCluggage G; McBride H; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin and catenin expression in normal and neoplastic endocervical glandular epithelium.
Heatley MK
Histopathology; 2004 Aug; 45(2):200-2. PubMed ID: 15279644
[No Abstract] [Full Text] [Related]
36. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
37. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells.
Reuschenbach M; Seiz M; von Knebel Doeberitz C; Vinokurova S; Duwe A; Ridder R; Sartor H; Kommoss F; Schmidt D; von Knebel Doeberitz M
Int J Cancer; 2012 Jan; 130(2):388-94. PubMed ID: 21387293
[TBL] [Abstract][Full Text] [Related]
39. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
Murphy N; Ring M; Heffron CC; King B; Killalea AG; Hughes C; Martin CM; McGuinness E; Sheils O; O'Leary JJ
J Clin Pathol; 2005 May; 58(5):525-34. PubMed ID: 15858126
[TBL] [Abstract][Full Text] [Related]
40. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
Shukla A; Thomas D; Roh MH
Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]